Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Janssen seeks FDA, EMA approvals for Simponi drug
The drug is used to treat adult patients with moderately to severely active ulcerative colitis (UC). Janssen Research and Development, Immunology Development head Jerome Boscia said they are
The drug is used to treat adult patients with moderately to severely active ulcerative colitis (UC). Janssen Research and Development, Immunology Development head Jerome Boscia said they are
The US Food and Drug Administration (FDA) suggested Cellceutix that an application for a 505(b)(2) designation for Prurisol will be an acceptable approach that allows the company to
Harvest, a Terumo Americas Holding company, is involved in developing point-of-care cellular platforms that isolate and concentrate autologous growth factors such as platelets and stem cells. RS Medical
The research conducted in collaboration with Merck showed that ADX88178 has the potential to improve the Parkinsonian symptoms as shown in two rodent models of dopamine depletion. Addex
Gluten and dairy-free Oxylent, which contains seven packets of the original Oxylent formula in a box, is available in three natural fruit flavors including sparkling berries, sparkling blackberry
The recall, which is based on the appearance of visible particles embedded in the glass located at the neck of the vial, is being conducted with the knowledge
Anushakti Chemicals is an associate company of Aarti with 49.67% stake, and is a manufacturer of various speciality chemicals used in performance chemicals, agrochemicals and pharmaceuticals. The company
The expansion will take the company’s footprint from its current 90,000ft² to approximately 200,000 ft². The first phase will double the cGMP capacity. Tris has received five new
No treatment-associated adverse events were observed in either of the patients in the study during the ERC dosing procedure, which involves a series of intramuscular injections in the
The Next Choice ONE DOSE (Levonorgestrel Tablet, 1.5mg) is the generic equivalent to Teva Women’s Health’s Plan B One-Step. The company plans to launch the product immediately. Plan